Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Innate Immune Cells and Early Fibrotic Repair After a Heart Attack

Official title: Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction

Run by Shanghai 10th People's Hospital · NCT07764588 · Data updated 2026-11-12

This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.

More Myocardial Infarction trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment50 (estimated)
SponsorShanghai 10th People's Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 14, 2026
Trial IDNCT07764588 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with acute STEMI planned for PPCI within 12 hours of symptom onset.

Probably not a fit

Patients who do not have STEMI or who cannot undergo MRI may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this observational study, 50 adults with STEMI undergoing PPCI will have blood samples analyzed for neutrophil and monocyte phenotypes, plus serum cytokines. Neutrophils will be sorted for transcriptome sequencing to explore gene expression patterns. At about one week after admission, participants will undergo cardiac MRI to measure the myocardial salvage index, LGE area, microvascular obstruction, extracellular volume, and LVEF to relate immune profiles to early fibrotic repair.

Why it matters

Potential benefit: If patterns are identified, this could help predict which patients are likelier to experience certain fibrotic responses after a heart attack.

How similar studies have gone: Previous work has shown associations between immune cell states and tissue repair in cardiovascular injury; this study builds on that by linking specific phenotypes to MRI-derived fibrosis metrics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\---- Age \> 18 and ≤ 80 years old

\- Patients with acute STEMI within 12 hours of symptom onset who are planned to receive PPCI

Exclusion Criteria:

* Prior revascularization
* Known allergy to gadopentetate dimeglumine contrast agent
* Pregnancy or planned pregnancy within the next 6 months
* Life expectancy \< 1 year
* Metallic implants or claustrophobia that precluded MRI
* Severe COPD or inability to hold breath for MRI
* Severe hepatic or renal dysfunction (ALT \> 5×ULN or eGFR \< 15 mL/min/1.73 m²)

Where it's running

  • Shanghai Tenth People's Hospital
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.